Organization
Forge Biologics
3 clinical trials
Clinical trial
A Long-term Follow-up Study to Evaluate Safety and Efficacy of Krabbe Patients From Gene Therapy Clinical Trials Involving the Administration of FBX-101 (AAVrh.10-hGALC)Status: Not yet recruiting, Estimated PCD: 2029-12-01
Clinical trial
A Phase 1b Clinical Study of Intravenous AAVrh10 Vector Expressing GALC in Krabbe Subjects Who Previously Received Hematopoietic Stem Cell Transplantation (REKLAIM)Status: Recruiting, Estimated PCD: 2026-07-01
Clinical trial
A Phase 1/2 Clinical Study of Intravenous Gene Transfer With an AAVrh10 Vector Expressing GALC in Krabbe Subjects Receiving Hematopoietic Stem Cell Transplantation (RESKUE)Status: Active (not recruiting), Estimated PCD: 2024-07-01